Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cheng-Chang Wu
Observed name:
Wu, Cheng-Chang
Institutions:
University of Colorado Cancer Center,
University of Colorado Anschutz
Observed institutions:
Colorado School of Public Health,
University of Colorado Cancer Center,
University of Colorado Anschutz
ORCID:
0009-0001-2539-6860
Observed ORCID:
0009-0001-2539-6860
OpenAlex ID:
A5125463501
Predicting Nurses’ Views on Decriminalization of Psychedelics
2025
·
Carolyn M. Porta
, Cheng-Chang Wu
, et al.
·
Psychedelic Medicine
·
2
Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial
2026
·
Jessica S. W. Borgers
, Cheng-Chang Wu
, et al.
·
Cancers
Epigenetic priming with oral decitabine/cedazuridine com-bined with nivolumab in unresectable or metastatic mucosal melanoma: Clinical and correlative findings from a phase Ib/II trial
2026
·
McCarter, Martin
, Couts, Kasey
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Epigenetic priming with oral decitabine/cedazuridine combined with nivolumab in unresectable or metastatic mucosal melanoma: Clinical and correlative findings from a phase Ib/II trial
2026
·
Couts, Kasey
, Tobin, Richard
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
An Open Benchmark for Systems Vaccinology: Insights from the CMI-PB Challenges
2026
·
Pramod Shinde
, Lisa Willemsen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Uptake of Fertility Preservation in Adolescents and Young Adults With a History of Ovarian Germ Cell and Sex Cord Stromal Tumors
2026
·
Kamilah Tebeau
, Guluzar Turan
, et al.
·
North American Proceedings in Gynecology and Obstetrics - Supplemental
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
2026
·
Jessica S.W. Borgers
, Cheng-Chang Wu
, et al.
·
Journal of the National Comprehensive Cancer Network
Show more works
View as search
Works count:
7
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type